Join the 'Anthrasil' group to help and get support from people like you.
Posted 1 Jul 2016 by Drugs.com
FRIDAY, July 1, 2016 – A vaccine made with a component of the bacteria that causes anthrax protected monkeys from the deadly infection in a preliminary trial. Previous research showed that this component – the anthrax capsule – played a pivotal role in providing protection, the researchers said. In this study, the same team of scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) tested a higher dose of the anthrax capsule vaccine in monkeys exposed to lethal inhaled levels of anthrax spores. All the monkeys that received the vaccine survived, while the non-vaccinated monkeys died from anthrax, according to the study published online June 27 in the journal Vaccine. The results suggest that anthrax capsule is a highly effective vaccine ingredient and should be considered for use in future anthrax vaccines, the researchers said. Current anthrax ... Read more
Related support groups: BCG, Prevnar 13, Prevnar, Tetanus Toxoid, Vivotif Berna, Typhoid Vaccine, Live, Pneumovax 23, Vivotif Berna Vaccine, Pneumococcal 23-polyvalent Vaccine, Tice BCG, Pertussis, Acellular, Pneumococcal 7-Valent Vaccine, Anthrax, Typhoid Vaccine, Inactivated, Menactra, Anthrax Prophylaxis, Meningococcal Polysaccharide Vaccine, Pneumococcal 13-valent Conjugate Vaccine, Typhim Vi, Cutaneous Bacillus anthracis